Xiaonan Zhang

Uppsala, C 75185, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Albacarcin V adds EPLIN as a novel and promising target for the treatment of female cancers and pediatric medulloblastoma.

Albacarcin V adds EPLIN as a novel and promising target for the treatment of female cancers and pediatric medulloblastoma.

Journal: Biochemical pharmacology

Published: October 09, 2025

NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors.

NAT2 activity increases cytotoxicity of anthracycline antibiotics and HDAC inhibitors.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: December 08, 2024

Identification of a small molecule targeting EPLIN as a novel strategy for the treatment of pediatric neuroblastoma and medulloblastoma.

Identification of a small molecule targeting EPLIN as a novel strategy for the treatment of pediatric neuroblastoma and medulloblastoma.

Journal: Cell death & disease

Published: September 23, 2024

Exploring the Enigma: The Role of the Epithelial Protein Lost in Neoplasm in Normal Physiology and Cancer Pathogenesis.

Exploring the Enigma: The Role of the Epithelial Protein Lost in Neoplasm in Normal Physiology and Cancer Pathogenesis.

Journal: International journal of molecular sciences

Published: April 01, 2024

Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib.

Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib.

Journal: EBioMedicine

Published: February 06, 2024

Identification of ATF3 as a novel protective signature of quiescent colorectal tumor cells.

Identification of ATF3 as a novel protective signature of quiescent colorectal tumor cells.

Journal: Cell death & disease

Published: July 06, 2023

Genetic differences between primary and metastatic cancer: a pan-cancer whole-genome comparison study.

Genetic differences between primary and metastatic cancer: a pan-cancer whole-genome comparison study.

Journal: Signal transduction and targeted therapy

Published: May 25, 2023

Quiescent Cancer Cells-A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse.

Quiescent Cancer Cells-A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse.

Journal: International journal of molecular sciences

Published: January 14, 2023

Emetine, a small molecule natural product, displays potent anti-gastric cancer activity via regulation of multiple signaling pathways.

Emetine, a small molecule natural product, displays potent anti-gastric cancer activity via regulation of multiple signaling pathways.

Journal: Cancer chemotherapy and pharmacology

Published: October 22, 2022

Iron Chelator VLX600 Inhibits Mitochondrial Respiration and Promotes Sensitization of Neuroblastoma Cells in Nutrition-Restricted Conditions.

Iron Chelator VLX600 Inhibits Mitochondrial Respiration and Promotes Sensitization of Neuroblastoma Cells in Nutrition-Restricted Conditions.

Journal: Cancers

Published: June 11, 2022

Enhanced cytotoxicity of a novel family of ATPase inhibitors in colorectal cancer cells with high NAT2 activity.

Enhanced cytotoxicity of a novel family of ATPase inhibitors in colorectal cancer cells with high NAT2 activity.

Journal: Biochemical pharmacology

Published: May 24, 2022

Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries.

Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries.

Journal: International journal of molecular sciences

Published: April 08, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026